These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37209247)

  • 1. Fabrication, characterization and evaluation of a new designed botulinum toxin-cell penetrating peptide nanoparticulate complex.
    Ravari NS; Sheikhlou MG; Goodarzi N; Kharazian B; Amini M; Atyabi F; Nasrollahi SA; Dinarvand R
    Daru; 2023 Jun; 31(1):1-12. PubMed ID: 37209247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
    Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
    Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy.
    Yin L; Masuyer G; Zhang S; Zhang J; Miyashita SI; Burgin D; Lovelock L; Coker SF; Fu TM; Stenmark P; Dong M
    PLoS Biol; 2020 Mar; 18(3):e3000618. PubMed ID: 32182233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of botulinum neurotoxin into cultured neurons.
    Keller JE; Cai F; Neale EA
    Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the rat digit abduction score (DAS) assay: Evaluation of botulinum neurotoxin activity in the gastrocnemius lateralis, peronei, and extensor digitorum longus.
    Cornet S; Périer C; Kalinichev M
    Toxicon X; 2020 Jun; 6():100029. PubMed ID: 32550584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A.
    Miyashita SI; Karatsu S; Fujiishi M; Huang IH; Nagashima Y; Morobishi T; Hosoya K; Hata T; Dong M; Sagane Y
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.
    Oshima M; Deitiker P; Jankovic J; Atassi MZ
    Immunol Invest; 2018 Jan; 47(1):18-39. PubMed ID: 28891721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
    Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O
    Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems.
    Elliott M; Maignel J; Liu SM; Favre-Guilmard C; Mir I; Farrow P; Hornby F; Marlin S; Palan S; Beard M; Krupp J
    PLoS One; 2017; 12(10):e0185628. PubMed ID: 28982136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia.
    Lam TI; Stanker LH; Lee K; Jin R; Cheng LW
    Cell Microbiol; 2015 Aug; 17(8):1133-43. PubMed ID: 25640773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Pharmacodynamics of Three Different Botulinum Toxin Type A Preparations following Repeated Intramuscular Administration in Mice.
    Byun J; Kwak S; Kwon JH; Shin M; Lee DK; Rhee CH; Kang WH; Oh JW; Cruz DJM
    Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution.
    Tang-Liu DD; Aoki KR; Dolly JO; de Paiva A; Houchen TL; Chasseaud LF; Webber C
    Toxicon; 2003 Oct; 42(5):461-9. PubMed ID: 14529727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel RRGW derived peptide is a promising inhibitor of BoNT/A.
    Ma W; Wang L; Tan X; Wang X; Yang C; Wang Y; Liu Z; Liu B; Zhu H; Zhi D; Wang D
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2203878. PubMed ID: 37106479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacodynamic comparison study of different botulinum toxin type A preparations.
    Kim SB; Ban B; Jung KS; Yang GH
    Dermatol Surg; 2013 Jan; 39(1 Pt 2):150-4. PubMed ID: 23301818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond neuromuscular activity: botulinum toxin type A exerts direct central action on spinal control of movement.
    Šoštarić P; Matić M; Nemanić D; Lučev Vasić Ž; Cifrek M; Pirazzini M; Matak I
    Eur J Pharmacol; 2024 Jan; 962():176242. PubMed ID: 38048980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
    Wortzman MS; Pickett A
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S34-42. PubMed ID: 19945003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
    Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of the synaptosome-binding regions on botulinum neurotoxin B.
    Dolimbek BZ; Steward LE; Aoki KR; Atassi MZ
    Biochemistry; 2012 Jan; 51(1):316-28. PubMed ID: 22146011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic neurological and biological effects by botulinum neurotoxin type A on SH-SY5Y neuroblastoma cells, beyond the blockade of neurotransmitter release.
    Wang L; Ringelberg CS; Singh BR
    BMC Pharmacol Toxicol; 2020 Sep; 21(1):66. PubMed ID: 32891179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.